Calviri

About Calviri

Calviri is a pioneering biotechnology company focused on developing groundbreaking cancer vaccines and diagnostic tests. Operating in the healthcare and life sciences market, Calviri serves a diverse range of clients, including medical institutions, research organizations, and pet owners. The company's core business model revolves around the research, development, and commercialization of cancer prevention and treatment solutions. Calviri generates revenue through the sale of its diagnostic tests and vaccines, as well as through research collaborations and clinical trials. The company has developed a unique vaccine that not only treats cancer but also prevents it from occurring in the first place. Additionally, Calviri's diagnostic tests aim to detect cancer at an early stage, improving patient outcomes and reducing healthcare costs. The company is actively engaged in clinical trials, including a significant study involving 800 dogs to test the efficacy of its cancer-preventing vaccine. Calviri's mission is to end cancer worldwide, leveraging its proprietary technologies and scientific breakthroughs to achieve this ambitious goal.